Merck's (MRK) Phase 3 Keytruda study met its primary endpoint of progression-free survival (PFS) for the treatment of patients with mismatch repair deficient (dMMR) advanced or recurrent endometrial cancer
Newsquawk Staff ·
Merck's (MRK) Phase 3 Keytruda study met its primary endpoint of progression-free survival (PFS) for the treatment of patients with mismatch repair deficient (dMMR) advanced or recurrent endometrial cancer.
Sources
- [EARNINGS CALL] Tesla (TSLA) CEO Elon Musk says the company will increase production to meet demand; company is aiming to produce approximately 5mln vehicles annually by 2030
- Newsquawk Daily Asia-Pac Opening News - 22nd October 2026
- US Market Wrap: Stocks gain as tech earnings begin
- US President Trump says on embassy staff told to depart, says don't know that they are; we continue to beat Iran
- US President Trump says closest they've ever been to settling Ukraine/Russia war
Related headlines
- [EARNINGS CALL] Meta (META) expects new AI businesses to generate incremental revenue from 2027 through subscriptions, transactions, advertising and enterprise offerings, with meaningful growth potential over time54 min ago
- [EARNINGS CALL] IBM (IBM) says Q3 revenue growth accelerated to 6%, above the base case outlined in July, with acceleration across segments, while management expressed confidence in its balance-of-year outlook, supported by strong profitability and FCF59 min ago
- [EARNINGS CALL] Lam Research (LRCX) says its preliminary CY27 wafer fabrication equipment outlook exceeds USD 200bln (exp. CY26 USD 150bln), driven by DRAM, NAND and foundry/logic demand1 hour ago
- [EARNINGS CALL] Meta (META) CFO expects compute efficiency to improve tenfold over the next year1 hour ago
- [EARNINGS CALL] Meta (META) outlook; Revenue Guidance 73bln-76bln, FY 2026 Total Expenses Guidance 175bln-179bln, FY 2026 Capex Guidance 135bln-145bln (prev. 130bln-145bln)1 hour ago
- [EARNINGS CALL] Meta (META) CEO says Co. expects to grow Muse to serve billions of people, adding that more than 10mln people in the US and Canada have set up Muse personal agents in just a month and a half1 hour ago
- Kinder Morgan Inc (KMI) Q3 2026 (USD): Adj. EPS 0.35 (exp. 0.32), Revenue 4.531bln (exp. 4.38bln)1 hour ago
- Meta (META) CEO Zuckerberg weighs relocating from California if Prop 40 is enacted, Bloomberg reports1 hour ago
- International Business Machines (IBM) EPS 16.8bln (exp. 2.86), Revenue 17.1bln (exp. 16.81bln); reaffirms FY revenue guidance; Raises outlook for full-year free cash flow2 hours ago
- Lam Research (LRCX) Q1 2027 (USD): Adj. EPS 2.20 (exp. 2.18), Revenue 8.22bln (exp. 8.13bln), 2 hours ago
- Meta Platforms Inc (META) Q3 2026 (USD): EPS 3.83 (exp. 6.67), Revenue 64.6bln (exp. 63.31bln)2 hours ago
- EQT said to near deal for Qiagen at EUR 46.50/shr, Bloomberg reports2 hours ago
- Walmart (WMT) introduces agent profiles and agent gateway for AI-enabled shopping, to launch in customer accounts next month2 hours ago
- Meta (META) plans to introduce new nonvoting stock to fund its AI investments without diluting CEO Zuckerberg's control, reports Semafor citing sources; could be announced as soon as today alongside earnings2 hours ago
- Meta (META) must pay USD 25bln in penalties, a New Mexico judge ruled after jury found company misled consumers about privacy4 hours ago